[1]
Robins, D.J. The Pyrrolizidine Alkaloids. In: Fortschritte der Chemie organischer Naturstoffe / Progress in the Chemistry of Organic Natural Products; Herz, W.; Grisebach, H.; Kirby, G.W., Eds.; Springer Vienna: Vienna, 1982; Vol. 41, pp. 115-202.
[2]
Pass, D.A.; Hogg, G.G.; Russell, R.G.; Edgar, J.A.; Tence, I.M.; Rikard-Bell, L. Poisoning of chickens and ducks by pyrrolizidine alkaloids of Heliotropium europaeum. Aust. Vet. J., 1979, 55, 284-288.
[3]
Bull, L.B.; Culvenor, C.C.J.; Dick, A.T. The pyrrolizidine Alkaloids: Their Chemistry-Pathogenicity and Other Biological Properties; North-Holland Pub. Co: Amsterdam, 1968.
[4]
Huxtable, R.J. New aspects of the toxicology and pharmacology of pyrrolizidine alkaloids. Gen. Pharmacol- Vasc. Sys., 1979, 10, 159-167.
[5]
Allen, J.R.; Hsu, I.C.; Carstens, L.A. Dehydroretronecine-induced rhabdomyosarcomas in rats. Cancer Res., 1975, 35, 997-1002.
[6]
Schoental, R.A. Sensitive analytical method for pyrrolizidine alkaloids. The mass spectra of retronecine derivatives. Cancer Res., 1975, 35, 2020-2024.
[7]
Deinzer, M.; Thomson, P.; Griffin, D.; Dickinson, E. A sensitive analytical method for pyrrolizidine alkaloids. The mass spectra of retronecine derivatives. Biomed. Mass Spectrom., 1978, 5, 175-179.
[8]
Dickinson, J.O.; Cooke, M.P.; King, R.R.; Mohamed, P.A. Milk transfer of pyrrolizidine alkoloids in cattle. J. Am. Vet. Med. Assoc., 1976, 169, 1192-1196.
[9]
Tandon, H.D.; Tandon, B.N.; Mattocks, A.R. An epidemic of veno-occlusive disease of the liver in Afghanistan. Pathologic features. Am. J. Gastroenterol., 1978, 70, 607-613.
[10]
Robertson, K.A.; Seymour, J.L.; Hsia, M-T.; Allen, J.R. Covalent interaction of dehydroretronecine, a carcinogenic metabolite of the pyrrolizidine alkaloid monocrotaline, with cysteine and glutathione. Cancer Res., 1977, 37, 3141-3144.
[11]
Schoental, R. Alkylation of coenzymes and the acute effects of alkylating hepatotoxins. FEBS Lett., 1976, 61, 111-114.
[12]
Kovach, J.S.; Ames, M.M.; Powis, G.; Moertel, C.G.; Hahn, R.G.; Creagan, E.T. Toxicity and pharmacokinetics of a pyrrolizidine alkaloid, indicine N-oxide, in humans. Cancer Res., 1979, 39, 4540-4544.
[13]
Atal, C.K. Semisynthetic derivatives of pyrrolizidine alkaloids of pharmacodynamic importance: A review. Lloydia, 1978, 41, 312-326.
[14]
Nash, R.J.; Fellows, L.E.; Dring, J.V.; Fleet, G.W.J.; Derome, A.E.; Hamor, T.A.; Scofield, A.M.; Watkin, D.J. Isolation from alexaleiopetala and X-ray crystal structure of alexine, (1r,2r,3r,7s,8s)-3-hydroxymethyl-1,2,7-tri-hydroxypyrrolizidine [(2r,3r,4r,5s,6s)-2-hydroxymethyl-1-azabicyclo[3.3.0] octan-3,4,6-triol], a unique pyrrolizidine alkaloid. Tetrahedron Lett., 1988, 29, 2487-2490.
[15]
Molyneux, R.J.; Benson, M.; Wong, R.Y.; Tropea, J.E.; Elbein, A.D. Australine, a Novel Pyrrolizidine Alkaloid Glucosidase Inhibitor from Castanospermum australe. J. Nat. Prod., 1988, 51, 1198-1206.
[16]
Nash, R.J.; Fellows, L.E.; Dring, J.V.; Fleet, G.W.J.; Girdhar, A.; Ramsden, N.G.; Peach, J.M.; Hegarty, M.P.; Scofield, A.M. Two alexines [3-hydroxymethyl-1,2,7-trihydroxypyrrolizidines] from Castanospermum australe. Phytochemistry, 1990, 29, 111-114.
[17]
Nash, R.J.; Fellows, L.E.; Plant, A.C.; Fleet, G.W.J.; Derome, A.E.; Baird, P.D.; Hegarty, M.P.; Scofield, A.M. Isolation from castanospermum australe and x-ray crystal structure of 3,8-diepialexine, (1r,2r,3s,7s,8r)-3-hydroxymethyl-1,2,7-trihydroxypyrrolizidine [(2s,3r,4r,5s,6r)-2-hydroxy-methyl-1-azabicyclo[3.3.0]octan-3,4,6-triol]. Tetrahedron, 1988, 44, 5959-5964.
[18]
Kato, A.; Kano, E.; Adachi, I.; Molyneux, R.J.; Watson, A.A.; Nash, R.J.; Fleet, G.W.J.; Wormald, M.R.; Kizu, H.; Ikeda, K.; Asano, N. Australine and related alkaloids: Easy structural confirmation by 13C NMR spectral data and biological activities. Tetrahedron, 2003, 14, 325-331.
[19]
Jones, L.; Hollinshead, J.; Fleet, G.W.J.; Thompson, A.L.; Watkin, D.J.; Gal, Z.A.; Jenkinson, S.F.; Kato, A.; Nash, R.J. Isolation of the pyrrolizidine alkaloid 1-epialexine from Castanospermum australe. Phytochem. Lett., 2010, 3, 133-135.
[20]
Asano, N.; Nash, R.J.; Molyneux, R.J.; Fleet, G.W.J. Sugar-mimic glycosidase inhibitors: natural occurrence, biological activity and prospects for therapeutic application. Tetrahedron, 2000, 11, 1645-1680.
[21]
Asano, N. Alkaloidal Sugar Mimetics: Biological Activities and Therapeutic Applications. J. Enzyme Inhib. Med. Chem., 2000, 15, 215-234.
[22]
Tropea, J.E.; Molyneux, R.J.; Kaushal, G.P.; Pan, Y.T.; Mitchell, M.; Elbein, A.D. Australine, a pyrrolizidine alkaloid that inhibits amyloglucosidase and glycoprotein processing. Biochemistry, 1989, 28, 2027-2034.
[23]
Taylor, D.L.; Nash, R.; Fellows, L.E.; Kang, M.S.; Tyms, A.S. Naturally occurring pyrrolizidines: Inhibition of α-glucosidase 1 and anti-HIV activity of one steroisomer. Antivir. Chem. Chemother., 1992, 3, 273-277.
[24]
Simmonds, M.S.J.; Blaney, W.M.; Fellows, L.E. Behavioral and electrophysiological study of antifeedant mechanisms associated with polyhydroxy alkaloids. J. Chem. Ecol., 1990, 16, 3167-3196.
[25]
Fellows, L.E.; Evans, S.V.; Nash, R.J.; Bell, E.A. Polyhydroxy plant alkaloids as glycosidase inhibitors and their possible ecological role. ACS Symp. Ser., 1986, 296, 72-78.
[26]
Nash, R.J.; Thomas, P.I.; Waigh, R.D.; Fleet, G.W.J.; Wormald, M.R. de Q. Lilley, P.M.; Watkin, D.J. Casuarine: A very highly oxygenated pyrrolizidine alkaloid. Tetrahedron Lett., 1994, 35, 7849-7852.
[27]
Chopra, R.N.; Nayar, S.L. Glossary of Indian Medicinal Plants; Council of Scientific and Industrial Research: New Delhi, 1956.
[28]
Wormald, M.; Nash, R.; Watson, A.; Bhadoria, B.; Langford, R.; Sims, M.; Fleet, G. Casuarine-6-α-D-glucoside from Casuarina equisetifolia and Eugenia jambolana. Carbohydr. Lett., 1996, 2, 169-174.
[29]
Davis, A.S.; Pyne, S.G.; Skelton, B.W.; White, A.H. Synthesis of Putative Uniflorine A. J. Org. Chem., 2004, 69, 3139-3143.
[30]
Matsumura, T.; Kasai, M.; Hayashi, T.; Arisawa, M.; Momose, Y.; Arai, I.; Amagaya, S.; Komatsu, Y. α-Glucosidase inhibitors from paraguayan natural medicine, nangapiry, the leaves of Eugenia uniflora. Pharm. Biol., 2000, 38, 302-307.
[31]
Ritthiwigrom, T.; Pyne, S.G. Synthesis of (+)-uniflorine a: A structural reassignment and a configurational assignment. Org. Lett., 2008, 10, 2769-2771.
[32]
Davis, A.S.; Ritthiwigrom, T.; Pyne, S.G. Synthetic and spectroscopic studies on the structures of uniflorines A and B: Structural revision to 1,2,6,7-tetrahydroxy-3-hydroxymethylpyrrolizidine alkaloids. Tetrahedron, 2008, 64, 4868-4879.
[33]
Karanjule, N.S.; Markad, S.D.; Dhavale, D.D. Synthesis of pentahydroxy indolizidine alkaloids using ring closing metathesis: Attempts to find the correct structure of uniflorine A. J. Org. Chem., 2006, 71, 6273-6276.
[34]
Zhao, Z.; Song, L.; Mariano, P.S. A concise sequential photochemical-metathesis approach for the synthesis of (+)-castanospermine and possible uniflorine-A stereoisomers. Tetrahedron, 2005, 61, 8888-8894.
[35]
Bell, A.A.; Pickering, L.; Watson, A.A.; Nash, R.J.; Griffiths, R.C.; Jones, M.G.; Fleet, G.W.J. 2-Hydroxycastanospermines (dihydroxy-L-swainsonines) from octonolactones: Inhibition of naringinase (L-rhamnosidase). Tetrahedron Lett., 1996, 37, 8561-8564.
[36]
Ameijde, J.V.; Horne, G.; Wormald, M.R.; Dwek, R.A.; Nash, R.J.; Jones, P.W.; Evinson, E.L.; Fleet, G.W.J. Isolation synthesis and glycosidase inhibition profile of 3-epi-casuarine. Tetrahedron Asymmetry, 2006, 17, 2702-2712.
[37]
The Angiosperm Phylogeny Group. An update of the Angiosperm Phylogeny Group classification for the orders and families of flowering plants: APG III. Bot. J. Linn. Soc., 2009, 161, 105-121.
[38]
Nash, R.; Watson, A.A.; Asano, N. Alkaloids: Chemical and biological Perspectives; Elsevier: Oxford, 1996, Vol. 11, .
[39]
Thursby-Pelham, R.H. Suspected Scilla non-scripta (bluebell) poisoning in cattle. Vet. Rec., 1967, 80, 709-710.
[40]
Watson, A.A.; Nash, R.J.; Wormald, M.R.; Harvey, D.J.; Dealler, S.; Lees, E.; Asano, N.; Kizu, H.; Kato, A.; Griffiths, R.C.; Cairns, A.J.; Fleet, G.W.J. Glycosidase-inhibiting pyrrolidine alkaloids from Hyacinthoides non- scripta. Phytochemistry, 1997, 46, 255-259.
[41]
Kato, A.; Adachi, I.; Miyauchi, M.; Ikeda, K.; Komae, T.; Kizu, H.; Kameda, Y.; Watson, A.A.; Nash, R.J.; Wormald, M.R.; Fleet, G.W.J.; Asano, N. Polyhydroxylated pyrrolidine and pyrrolizidine alkaloids from Hyacinthoides non-scripta and Scilla campanulata. Carbohydr. Res., 1999, 316, 95-103.
[42]
Asano, N.; Kuroi, H.; Ikeda, K.; Kizu, H.; Kameda, Y.; Kato, A.; Adachi, I.; Watson, A.A.; Nash, R.J.; Fleet, G.W.J. New polyhydroxylated pyrrolizidine alkaloids from Muscari armeniacum: Structural determination and biological activity. Tetrahedron Asymmetry, 2000, 11, 1-8.
[43]
Mehta, A.; Zitzmann, N.; Rudd, P.M.; Block, T.M.; Dwek, R.A. α-Glucosidase inhibitors as potential broad based anti-viral agents. FEBS Lett., 1998, 430, 17-22.
[44]
Watson, A.A.; Fleet, G.W.; Asano, N.; Molyneux, R.J.; Nash, R.J. Polyhydroxylated alkaloids - natural occurrence and therapeutic applications. Phytochemistry, 2001, 56, 265-295.
[45]
Platt, F.M.; Neises, G.R.; Reinkensmeier, G.; Townsend, M.J.; Perry, V.H.; Proia, R.L.; Winchester, B.; Dwek, R.A.; Butters, T.D. Prevention of lysosomal storage in tay-sachs mice treated with N-butyldeoxynojirimycin. Science, 1997, 276, 428-431.
[46]
Cox, T.; Lachmann, R.; Hollak, C.; Aerts, J.; van Weely, S.; Hrebícek, M.; Platt, F.; Butters, T.; Dwek, R.; Moyses, C.; Gow, I.; Elstein, D.; Zimran, A. Novel oral treatment of Gaucher’s disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis. Lancet, 2000, 355, 1481-1485.
[47]
Fan, J-Q.; Ishii, S.; Asano, N.; Suzuki, Y. Accelerated transport and maturation of lysosomal α-galactosidase A in Fabry lymphoblasts by an enzyme inhibitor. Nat. Med., 1999, 5, 112-115.
[48]
Yamashita, T.; Yasuda, K.; Kizu, H.; Kameda, Y.; Watson, A.A.; Nash, R.J.; Fleet, G.W.J.; Asano, N. New polyhydroxylated pyrrolidine, piperidine, and pyrrolizidine alkaloids from Scilla sibirica. J. Nat. Prod., 2002, 65, 1875-1881.
[49]
Asano, N.; Ikeda, K.; Kasahara, M.; Arai, Y.; Kizu, H. Glycosidase-inhibiting pyrrolidines and pyrrolizidines with a long side chain in Scilla peruviana. J. Nat. Prod., 2004, 67, 846-850.
[50]
Kato, A.; Kato, N.; Adachi, I.; Hollinshead, J.; Fleet, G.W.J.; Kuriyama, C.; Ikeda, K.; Asano, N.; Nash, R.J. Isolation of glycosidase-inhibiting hyacinthacines and related alkaloids from Scilla socialis. J. Nat. Prod., 2007, 70, 993-997.
[51]
Chabaud, L.; Landais, Y.; Renaud, P. Total synthesis of hyacinthacine A1 and 3-epi-hyacinthacine A1. Org. Lett., 2005, 7, 2587-2590.
[52]
Rambaud, L.; Compain, P.; Martin, O.R. First total synthesis of (+)-hyacinthacine A2. Tetrahedron Asymmetry, 2001, 12, 1807-1809.
[53]
Izquierdo, I.; Plaza, M.T.; Franco, F. Polyhydroxylated pyrrolizidines. Part 2: The first total synthesis of (+)-hyacinthacine A3. Tetrahedron, 2002, 13, 1581-1585.
[54]
Zhang, T-X.; Zhou, L.; Cao, X-P. First Total synthesis of hyacinthacine a6 from the protected derivative of polyhydroxylated pyrrolidine. Chem. Res. Chin. Univ., 2008, 24, 469-472.
[55]
Donohoe, T.J.; Thomas, R.E.; Cheeseman, M.D.; Rigby, C.L.; Bhalay, G.; Linney, I.D. Flexible strategy for the synthesis of pyrrolizidine alkaloids. Org. Lett., 2008, 10, 3615-3618.
[56]
Izquierdo, I.; Plaza, M.T.; Tamayo, J.A.; Yáñez, V.; Lo Re, D.; Sánchez-Cantalejo, F. First total synthesis and absolute configuration of naturally occurring (−)-hyacinthacine A7 and its (−)-1-epi-isomer. Tetrahedron, 2008, 64, 4613-4618.
[57]
Sengoku, T.; Satoh, Y.; Oshima, M.; Takahashi, M.; Yoda, H. First asymmetric synthesis of pyrrolizidine alkaloids, (+)-hyacinthacine B1 and (+)-B2. Tetrahedron, 2008, 64, 8052-8058.
[58]
Au, C.W.G.; Nash, R.J.; Pyne, S.G. Synthesis of hyacinthacine B3 and purported hyacinthacine B7. Chem. Commun., 2010, 46, 713-715.
[59]
Savaspun, K.; Au, C.W.G.; Pyne, S.G. Total synthesis of hyacinthacines B3, B4, and B5 and purported hyacinthacine B7, 7-epi-hyacinthacine B7, and 7a-epi-hyacinthacine B3 from a common precursor. J. Org. Chem., 2014, 79, 4569-4581.
[60]
Sengoku, T.; Satoh, Y.; Takahashi, M.; Yoda, H. Total synthesis of the proposed structures of hyacinthacines C2, C3, and their C5-epimers. Tetrahedron Lett., 2009, 50, 4937-4940.
[61]
Zhang, W.; Sato, K.; Kato, A.; Jia, Y-M.; Hu, X-G.; Wilson, F.X.; van Well, R.; Horne, G.; Fleet, G.W.J.; Nash, R.J.; Yu, C-Y. Synthesis of fully substituted polyhydroxylated pyrrolizidines via cope–house cyclization. Org. Lett., 2011, 13, 4414-4417.
[62]
Tamayo, J.A.; Franco, F.; Sánchez-Cantalejo, F. Synthesis of the proposed structure of pentahydroxylated pyrrolizidine hyacinthacine C5 and Its C6,C7 epimer. Eur. J. Org. Chem., 2011, 35, 7182-7188.
[63]
Pecchioli, T.; Cardona, F.; Reissig, H-U.; Zimmer, R.; Goti, A. alkoxyallene-based stereodivergent syntheses of (−)-hyacinthacine B4 and of putative hyacinthacine C5 epimers: Proposal of hyacinthacine C5 structure. J. Org. Chem., 2017, 82, 5835-5844.
[64]
Carroll, A.W.; Savaspun, K.; Willis, A.C.; Hoshino, M.; Kato, A.; Pyne, S.G. Total synthesis of natural hyacinthacine C5 and six related hyacinthacine C5 epimers. J. Org. Chem., 2018, 83, 5558-5576.
[65]
Muniraju, C.; Rao, M.V.; Rajender, A.; Rao, B.V. A common approach to the total synthesis of l-1-deoxyallonojirimycin, l-homo-1-deoxyazaallose and triacetyl derivative of 5-epi-hyacinthacine A5. Tetrahedron Lett., 2016, 57, 1763-1766.
[66]
Izquierdo, I.; Plaza, M.T.; Tamayo, J.A.; Sánchez-Cantalejo, F. Total synthesis of the 5-epimers of naturally occurring (-)-hyacinthacine A5 and unnatural (+)-hyacinthacine A4. Tetrahedron, 2007, 18, 2211-2217.
[67]
Robertson, J.; Stevens, K. Pyrrolizidine alkaloids. Nat. Prod. Rep., 2014, 31, 1721-1788.
[68]
Robertson, J.; Stevens, K. Pyrrolizidine alkaloids: Occurrence, biology, and chemical synthesis. Nat. Prod. Rep., 2017, 34, 62-89.
[69]
Tamariz, J.; Burgueño-Tapia, E.; Vázquez, M.A.; Delgado, F. Pyrrolizidine Alkaloids. In: The Alkaloids: Chemistry and Biology; Knölker, H-J., Ed.; Academic Press, 2018; Vol. 80, pp. 1-314.
[70]
Ritthiwigrom, T.; Au, W.G.C.; Pyne, G.S. Structure, biological activities and synthesis of hyacinthacine alkaloids and their stereoisomers. Curr. Org. Synth., 2012, 9, 583-612.
[71]
Tamayo, J.A.; Franco, F.; Re, D.L.; Sánchez-Cantalejo, F. Synthesis of pentahydroxylated pyrrolizidines and indolizidines. J. Org. Chem., 2009, 74, 5679-5682.
[72]
Tamayo, J.A.; Franco, F.; Sánchez-Cantalejo, F. Synthesis of unnatural pentahydroxylated pyrrolizidines: 5-epi- and 5,7a-di-epi-hyacinthacine C1. Tetrahedron, 2010, 66, 7262-7267.
[73]
Izquierdo, I.; Plaza, M.T.; Tamayo, J.A.; Franco, F.; Sánchez-Cantalejo, F. Total synthesis of natural (+)-hyacinthacine A6 and non-natural (+)-7a-epi-hyacinthacine A1 and (+)-5,7a-di-epi-hyacinthacine A6. Tetrahedron, 2010, 66, 3788-3794.
[74]
Beňadiková, D.; Medvecký, M.; Filipová, A.; Moncol, J.; Gembický, M.; Prónayová, N.; Fischer, R. New synthetic approach to C5-hydroxymethyl-substituted polyhydroxylated pyrrolizidines. Synlett, 2014, 25, 1616-1620.
[75]
Lahiri, R.; Palanivel, A.; Kulkarni, S.A.; Vankar, Y.D. Synthesis of isofagomine–pyrrolidine hybrid sugars and analogues of (−)-steviamine and (+)-hyacinthacine C5 using 1,3-dipolar cycloaddition reactions. J. Org. Chem., 2014, 79, 10786-10800.
[76]
Palanivel, A.; Dharuman, S.; Vankar, Y.D. Synthesis of analogues of hyacinthacines, casuarine and uniflorine A from C-2 formyl galactal. Tetrahedron, 2016, 27, 1088-1100.
[77]
Appel, R. Tertiary phosphane/tetrachloromethane, a versatile reagent for chlorination, dehydration, and P-N linkage. Angew. Chem. Int. Ed. Engl., 1975, 14, 801-811.
[78]
Jasiński, M.; Moreno-Clavijo, E.; Reissig, H-U. Synthesis of a series of enantiopure polyhydroxylated bicyclic N-heterocycles from an L-erythrose-derived nitrone and alkoxyallenes. Eur. J. Org. Chem., 2014, 2, 442-454.
Download PDF Flyer